Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
Public ClinicalTrials.gov record NCT03530293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of NBI-98854 in Pediatric Subjects With Tourette Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, double-blind, placebo-controlled, randomized withdrawal study to evaluate the safety and maintenance of efficacy of an optimized once-daily (qd) dose of NBI-98854 in pediatric subjects with TS.
Study identification
- NCT ID
- NCT03530293
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 17, 2018 (Actual)
- Primary completion
- Jul 16, 2019 (Actual)
- Completion
- Jul 16, 2019 (Actual)
- Last update posted
- May 17, 2022
2018 – 2019
United States locations
- U.S. sites
- 48
- U.S. states
- 22
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neuricrine Clinical Site | Sun City | Arizona | 85351 | — |
| Neurocrine Clinical Site | Little Rock | Arkansas | 72205 | — |
| Neurocrine Clinical Site | Rogers | Arkansas | 72758 | — |
| Neurocrine Clinical Site | Anaheim | California | 92805 | — |
| Neurocrine Clinical Site | Fullerton | California | 92835 | — |
| Neurocrine Clinical Site | San Diego | California | 92108 | — |
| Neurocrine Clinical Site | Santa Ana | California | 92705 | — |
| Neurocrine Clinical Site | Pueblo | Colorado | 81003 | — |
| Neurocrine Clinical Site | Stamford | Connecticut | 06905 | — |
| Neurocrine Clinical Site | Washington D.C. | District of Columbia | 22207 | — |
| Neurocrine Clinical Site | Gulf Breeze | Florida | 32561 | — |
| Neurocrine Clinical Site | Hialeah | Florida | 33012 | — |
| Neurocrine Clinical Site | Miami | Florida | 33125 | — |
| Neurocrine Clinical Site | Miami | Florida | 33136 | — |
| Neurocrine Clinical Site | North Miami | Florida | 33161 | — |
| Neurocrine Clinical Site | Orlando | Florida | 32803 | — |
| Neurocrine Clinical Site | Palmetto Bay | Florida | 33157 | — |
| Neurocrine Clinical Site | Spring Hill | Florida | 34609 | — |
| Neurocrine Clinical Site | St. Petersburg | Florida | 33701 | — |
| Neurocrine Clinical Site | Tallahassee | Florida | 32308 | — |
| Neurocrine Clinical Site | Atlanta | Georgia | 30338 | — |
| Neurocrine Clinical Site | Fayetteville | Georgia | 30214 | — |
| Neurocrine Clinical Site | Savannah | Georgia | 31406 | — |
| Neurocrine Clinical Site | Chicago | Illinois | 60634 | — |
| Neurocrine Clinical Site | South Bend | Indiana | 46617 | — |
| Neurocrine Clinical Site | Boston | Massachusetts | 02114 | — |
| Neurocrine Clinical Site | Ann Arbor | Michigan | 48015 | — |
| Neurocrine Clinical Site | Bloomfield Hills | Michigan | 48302 | — |
| Neurocrine Clinical Site | West Bloomfield | Michigan | 48322 | — |
| Neurocrine Clinical Site | Lincoln | Nebraska | 68526 | — |
| Neurocrine Clinical Site | Nashua | New Hampshire | 03060 | — |
| Neurocrine Clinical Site | Cherry Hill | New Jersey | 08002 | — |
| Neurocrine Clinical Site | Mount Arlington | New Jersey | 07856 | — |
| Neurocrine Clinical Site | New York | New York | 10036 | — |
| Neurocrine Clinical Site | South Setauket | New York | 11720 | — |
| Neurocrine Clinical Site | Charlotte | North Carolina | 29141 | — |
| Neurocrine Clinical Site | Mason | Ohio | 45040 | — |
| Neurocrine Clinical Site | Oklahoma City | Oklahoma | 73112 | — |
| Neurocrine Clinical Site | Dallas | Texas | 75243 | — |
| Neurocrine Clinical Site | DeSoto | Texas | 75115 | — |
| Neurocrine Clinical Site | Houston | Texas | 77030 | — |
| Neurocrine Clinical Site | Houston | Texas | 77058 | — |
| Neurocrine Clinical Site | Irving | Texas | 75062 | — |
| Neurocrine Clinical Site | San Antonio | Texas | 78249 | — |
| Neurocrine Clinical Site | Charlottesville | Virginia | 22903 | — |
| Neurocrine Clinical Site | Bothell | Washington | 98011 | — |
| Neurocrine Clinical Site | Everett | Washington | 98201 | — |
| Neurocrine Clinical Site | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03530293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2022 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03530293 live on ClinicalTrials.gov.